Guangzhou LBP Medicine Science & Technology Co Ltd (SHG:688393) — Stock Price
Guangzhou LBP Medicine Science & Technology Co Ltd (SHG:688393) is currently trading at CN¥20.25 CNY, up 2.95% today. Over the past 52 weeks, shares have ranged between CN¥16.21 and CN¥34.80. This page tracks Guangzhou LBP Medicine Science & Technology Co Ltd's live share price on the SHG exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Guangzhou LBP Medicine Science & Technol.
Guangzhou LBP Medicine Science & Technology Co Ltd (688393) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Guangzhou LBP Medicine Science & Technology Co Ltd's daily closing share price and trading volume on the SHG exchange over the past year, giving a clear view of recent price momentum and liquidity.
Guangzhou LBP Medicine Science & Technology Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Guangzhou LBP Medicine Science & Technology Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CN¥470.79 Million | CN¥497.29 Million | CN¥507.38 Million | CN¥438.99 Million | CN¥375.43 Million |
| Cost of Revenue | CN¥154.26 Million | CN¥161.87 Million | CN¥146.75 Million | CN¥96.95 Million | CN¥75.96 Million |
| Gross Profit | CN¥316.53 Million | CN¥335.42 Million | CN¥360.63 Million | CN¥342.04 Million | CN¥299.47 Million |
| Research & Development | CN¥40.90 Million | CN¥62.69 Million | CN¥67.39 Million | CN¥45.90 Million | CN¥27.73 Million |
| SG&A | CN¥4.08 Million | CN¥77.13 Million | CN¥20.45 Million | CN¥18.91 Million | CN¥10.62 Million |
| Total Operating Expenses | CN¥305.53 Million | CN¥319.10 Million | CN¥329.02 Million | CN¥275.00 Million | CN¥203.73 Million |
| Operating Income | CN¥11.00 Million | CN¥21.51 Million | CN¥38.85 Million | CN¥88.94 Million | CN¥100.20 Million |
| EBITDA | CN¥50.84 Million | CN¥66.48 Million | CN¥71.39 Million | CN¥111.26 Million | CN¥111.57 Million |
| EBIT | CN¥10.09 Million | CN¥19.47 Million | CN¥31.71 Million | CN¥89.34 Million | CN¥99.93 Million |
| Interest Expense | CN¥854.87K | CN¥808.03K | CN¥1.36 Million | CN¥384.10K | CN¥73.77K |
| Income Before Tax | CN¥9.43 Million | CN¥16.85 Million | CN¥28.79 Million | CN¥88.72 Million | CN¥99.85 Million |
| Income Tax Expense | CN¥-5.47 Million | CN¥-4.17 Million | CN¥-539.23K | CN¥13.44 Million | CN¥16.23 Million |
| Net Income | CN¥21.29 Million | CN¥40.06 Million | CN¥29.33 Million | CN¥79.78 Million | CN¥84.75 Million |
Guangzhou LBP Medicine Science & Technology Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Guangzhou LBP Medicine Science & Technology Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CN¥1.36 Billion | CN¥1.40 Billion | CN¥1.39 Billion | CN¥1.37 Billion | CN¥1.29 Billion |
| Total Current Assets | CN¥692.25 Million | CN¥567.57 Million | CN¥595.08 Million | CN¥909.17 Million | CN¥1.06 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥55.33 Million | CN¥52.56 Million | CN¥175.54 Million | CN¥419.42 Million | CN¥210.46 Million |
| Net Receivables | CN¥247.21 Million | CN¥245.25 Million | CN¥239.03 Million | CN¥211.94 Million | CN¥185.47 Million |
| Inventory | CN¥84.44 Million | CN¥74.97 Million | CN¥63.07 Million | CN¥40.57 Million | CN¥25.05 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | CN¥26.46 Million | CN¥26.46 Million | CN¥29.52 Million | CN¥29.52 Million | CN¥8.09 Million |
| Total Liabilities | CN¥130.99 Million | CN¥161.63 Million | CN¥170.45 Million | CN¥155.96 Million | CN¥124.67 Million |
| Total Current Liabilities | CN¥84.51 Million | CN¥110.33 Million | CN¥114.26 Million | CN¥106.84 Million | CN¥87.41 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | CN¥-86.20 Million | CN¥-35.85 Million | CN¥-66.11 Million | CN¥-205.28 Million | CN¥-633.50 Million |
| Total Stockholder Equity | CN¥1.26 Billion | CN¥1.26 Billion | CN¥1.23 Billion | CN¥1.20 Billion | CN¥1.17 Billion |
| Retained Earnings | CN¥381.37 Million | CN¥374.12 Million | CN¥347.62 Million | CN¥333.42 Million | CN¥287.15 Million |
Guangzhou LBP Medicine Science & Technology Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Guangzhou LBP Medicine Science & Technology Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥3.54 Million | CN¥17.12 Million | CN¥9.72 Million | CN¥59.61 Million | CN¥91.43 Million |
| Capital Expenditures | CN¥23.65 Million | CN¥37.74 Million | CN¥72.17 Million | CN¥143.34 Million | CN¥62.45 Million |
| Free Cash Flow | CN¥-20.10 Million | CN¥-20.62 Million | CN¥-62.45 Million | CN¥-83.73 Million | CN¥28.98 Million |
| Investing Cash Flow | CN¥57.12 Million | CN¥-32.70 Million | CN¥-114.92 Million | CN¥-446.61 Million | CN¥-183.31 Million |
| Financing Cash Flow | CN¥-34.72 Million | CN¥-6.89 Million | CN¥-21.40 Million | CN¥-29.53 Million | CN¥639.33 Million |
| Dividends Paid | CN¥14.51 Million | CN¥13.47 Million | CN¥25.20 Million | CN¥26.14 Million | — |
| Stock-Based Compensation | — | — | CN¥7.61 Million | CN¥7.36 Million | — |
| Depreciation | CN¥40.75 Million | CN¥40.99 Million | CN¥35.69 Million | CN¥18.58 Million | CN¥10.46 Million |
| Change in Cash | CN¥25.82 Million | CN¥-22.39 Million | CN¥-126.46 Million | CN¥-416.58 Million | CN¥547.35 Million |
Guangzhou LBP Medicine Science & Technology Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Guangzhou LBP Medicine Science & Technology Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 21, 2025 | — | — | — |
| Oct 30, 2024 | — | — | — |
| Aug 14, 2023 | 0.11 | — | — |
| Apr 20, 2023 | 0.08 | — | — |
| Dec 31, 2022 | -0.01 | — | — |
| Sep 30, 2022 | 0.09 | — | — |
| Jun 30, 2022 | 0.17 | — | — |
| Apr 01, 2022 | 0.06 | — | — |